NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Teitur Trophics

Teitur Trophics

Private
AarhusHealthcare & Life Scienceshttps://www.teiturtrophics.com/

Last Round

Series A

Mar 14, 2023

Total Funding Raised

$33.28M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Teitur Trophics is a biotechnology company that develops first-in-class peptide-based therapies for neurodegenerative diseases such as Parkinson's and Huntington's Disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyneurodegenerative diseasepeptide therapeuticsdrug discoveryclinical trialscyclic peptidebiotechdrug developmentParkinson's diseaseHuntington's diseasefrontotemporal dementianeuroscienceclinical-stage biotechpharmabiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Teitur Trophics Comparables

Compare Teitur Trophics with similar companies based on industry and business-model similarity.

Teitur Trophics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vesper Bio ApS
84%
Johnson & Johnson
81%
Axoltis Pharma
78%

Teitur Trophics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 14, 2023
SeedDec 21, 2021
SeedOct 1, 2020
AcceleratorJan 1, 2020

Key People

Founding team and executive leadership

Torgeir Vaage

Chief Financial Officer

Executive Team

Teitur Trophics Investors

Notable investors and investment history

Teitur Trophics investors
InvestorRounds
InnovestorSeries A
IndustrifondenSeries A
P53 InvestSeries A
Sunstone Life Science VenturesSeries A, Seed
BioInnovation InstituteAccelerator, Seed
Sound BioventuresSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors grew 829% MoM, from 124 to 1.2K.

Teitur Trophics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Teitur Trophics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Teitur Trophics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAarhus
Employee Range26
Year Founded2020
Last FundingMar 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.